LIPOSANA Trademark

Trademark Overview

On Friday, August 5, 2022, a trademark application was filed for LIPOSANA with the United States Patent and Trademark Office. The USPTO has given the LIPOSANA trademark a serial number of 97536321. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Britecyte Inc.. The LIPOSANA trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue composed of lyophilized adipose for medical treatment of soft tissue defect
liposana

General Information

Serial Number97536321
Word MarkLIPOSANA
Filing DateFriday, August 5, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7422937
Registration DateTuesday, June 18, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Description of MarkThe mark consists of the word Liposana with a curving solid line of varying widths to the left of the L and continuing beneath the entire word.
Goods and ServicesHuman allograft tissue composed of lyophilized adipose for medical treatment of soft tissue defect
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 26, 2022
Primary Code005
First Use Anywhere DateTuesday, August 8, 2023
First Use In Commerce DateTuesday, August 8, 2023

Trademark Owner History

Party NameBritecyte Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21045
Party NameBritecyte Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressColumbia, MD 21045
Party NameBritecyte Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressColumbia, MD 21045

Trademark Events

Event DateEvent Description
Tuesday, August 9, 2022NEW APPLICATION ENTERED
Friday, August 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 27, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 1, 2023ASSIGNED TO EXAMINER
Tuesday, February 7, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 18, 2023AMENDMENT AFTER NOA NOT ENTERED
Friday, August 18, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 12, 2023USE AMENDMENT FILED
Thursday, October 12, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, November 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, December 1, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, December 1, 2023NON-FINAL ACTION E-MAILED
Friday, December 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2024ASSIGNED TO LIE
Wednesday, April 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 1, 2024SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 1, 2024NON-FINAL ACTION E-MAILED
Friday, May 10, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, May 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2024SU-EXAMINER'S AMENDMENT WRITTEN
Friday, May 10, 2024EXAMINERS AMENDMENT E-MAILED
Friday, May 10, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

liposana tissue treatment soft medical defect lyophilized allograft composed human adipose